Book review: Oxford textbook of oncology, 3rd edition Andrew Davies Book Review 03 November 2016 Pages: 1 - 1
Emergency oncology: development, current position and future direction in the USA and UK Tim CooksleyTerry Rice Commentary 04 November 2016 Pages: 3 - 7
Effects of resistance exercise in women with or at risk for breast cancer-related lymphedema Emily SimonaviceJeong-Su KimLynn Panton Original Article 11 August 2016 Pages: 9 - 15
A tiered multidisciplinary approach to the psychosocial care of adult cancer patients integrated into routine care: the PROMPT study (a cluster-randomised controlled trial) Jane TurnerBrian KellyLisa Mackenzie Original Article 17 August 2016 Pages: 17 - 26
Treating an oft-unrecognized and troublesome entity: using gastric electrical stimulation to reduce symptoms of malignancy-associated gastroparesis Hamza ShahGregg WendorfThomas L. Abell Original Article 17 August 2016 Pages: 27 - 31
Four-week prehabilitation program is sufficient to modify exercise behaviors and improve preoperative functional walking capacity in patients with colorectal cancer Brian P. ChenRashami AwasthiCelena Scheede-Bergdahl Original Article 18 August 2016 Pages: 33 - 40
Predictors of responses to corticosteroids for anorexia in advanced cancer patients: a multicenter prospective observational study Naoki MatsuoTatsuya MoritaSatoru Iwase Original Article 18 August 2016 Pages: 41 - 50
Adapting an Australian question prompt list in oncology to a Norwegian setting—a combined method approach Anita AmundsenBente ErvikTone Nordøy Original Article 19 August 2016 Pages: 51 - 58
Venous thromboembolism treatment outcomes in cancer patients and effect of third-party payers on anticoagulant choice Gary W. JeanKatherine KellyRandall Hughes Original Article 20 August 2016 Pages: 59 - 66
Quantification of patient-reported outcome measures of radiation-induced skin reactions for use in clinical trial design N. S. RussellE. van WerkhovenS. B. Schagen Original Article 24 August 2016 Pages: 67 - 74
Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis Albert J. FariasIndia J. OrnelasBeti Thompson Original Article 24 August 2016 Pages: 75 - 83
Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy Martin ChasenLaszlo UrbanCesare Gridelli Original Article Open access 24 August 2016 Pages: 85 - 92
Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study Vanessa L. BeesleyB. Mark SmithersAdèle C. Green Original Article 25 August 2016 Pages: 93 - 102
Feasibility of implementing the ‘Screening for Distress and Referral Need’ process in 23 Dutch hospitals F. M. van NuenenS. M. DonofrioJ. E. H. M. Hoekstra-Weebers Original Article Open access 26 August 2016 Pages: 103 - 110
Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR) Alberto BongiovanniManuela MontiToni Ibrahim Original Article 27 August 2016 Pages: 111 - 117
What do adolescents and young adults want from cancer resources? Insights from a Delphi panel of AYA patients Christabel K. CheungBrad Zebrack Original Article 31 August 2016 Pages: 119 - 126
A guided self-help intervention targeting psychological distress among head and neck cancer and lung cancer patients: motivation to start, experiences and perceived outcomes Anne-Marie H KrebberCornelia F van Uden-KraanIrma M Verdonck-de Leeuw Original Article Open access 01 September 2016 Pages: 127 - 135
Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia Jennifer SmithChristine PoonIan Kerridge Original Article 02 September 2016 Pages: 137 - 144
Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: a randomized controlled study Sandip MukhopadhyayGagandeep KwatraDinesh Badyal Original Article 03 September 2016 Pages: 145 - 154
Erratum to: Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: a randomized controlled study Sandip MukhopadhyayGagandeep KwatraDinesh Badyal Erratum 27 September 2016 Pages: 155 - 156
Experiences of incontinence and pelvic floor muscle training after gynaecologic cancer treatment Anna LindgrenG. DunbergerA. Enblom Original Article Open access 05 September 2016 Pages: 157 - 166
Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer Angela StarkweatherDebra Lynch KellyDebra E. Lyon Original Article 06 September 2016 Pages: 167 - 176
Impact of outpatient palliative care (PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan Omar ShamiehOdai KhamashDavid Hui Original Article 07 September 2016 Pages: 177 - 183
The influence of dyadic symptom distress on threat appraisals and self-efficacy in advanced cancer and caregiving Katrina R. EllisMary R. JanevicLaurel Northouse Original Article 08 September 2016 Pages: 185 - 194
A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN) Janet M. SchlossMaree ColosimoLuis Vitetta Original Article 09 September 2016 Pages: 195 - 204
Infusion reactions are common after high-dose carmustine in BEAM chemotherapy and are not reduced by lengthening the time of administration Sarah PerreaultJulie BakerDennis L. Cooper Original Article 10 September 2016 Pages: 205 - 208
Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care A. AntonuzzoE. VasileS. Ricci Original Article 11 September 2016 Pages: 209 - 212
Patient- and family-centered care: a qualitative exploration of oncologist perspectives Timothy K. NguyenGlenn S. BaumanKarin Hahn Original Article 11 September 2016 Pages: 213 - 219
Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology Jessica E MorganHadeel HassanRobert S Phillips Original Article 11 September 2016 Pages: 221 - 228
Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients Ali AlkanArzu YaşarHakan Akbulut Original Article 12 September 2016 Pages: 229 - 236
Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits L. J. FallowfieldS. L. CattV. A. Jenkins Original Article 13 September 2016 Pages: 237 - 244
The multidimensional burden of informal caregivers in primary malignant brain tumor Eléonore BayenFlorence Laigle-DonadeyJean-Yves Delattre Original Article 13 September 2016 Pages: 245 - 253
Psychological distress of cancer patients with children under 18 years and their partners—a longitudinal study of family relationships using dyadic data analysis Heide GötzeMichael FriedrichJochen Ernst Original Article 13 September 2016 Pages: 255 - 264
MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update A. MolassiotisM. AaproF. Roila Special Article 08 August 2016 Pages: 267 - 269
2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents Karin JordanAlexandre ChanPaul J. Hesketh Special Article 08 August 2016 Pages: 271 - 275
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy Jørn HerrstedtFausto RoilaMatti S. Aapro Special Article 22 July 2016 Pages: 277 - 288
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy Fausto RoilaDavid WarrBernardo Rapoport Special Article 11 August 2016 Pages: 289 - 294
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy Fausto RoilaDavid WarrBernardo Rapoport Erratum 14 September 2016 Pages: 295 - 296
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential Ian OlverChristina H. RuhlmannRebecca Clark-Snow Special Article 30 August 2016 Pages: 297 - 301
2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting Lawrence H. EinhornBernardo RapoportMary J. Brames Special Article 04 November 2016 Pages: 303 - 308
2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting Christina H. RuhlmannFranziska JahnPetra Feyer Special Article 13 September 2016 Pages: 309 - 316
2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy L. Lee DupuisJoseph A. RoscoeAlexander Molassiotis Special Article 10 August 2016 Pages: 317 - 321
2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children L. Lee DupuisLillian SungMarianne van de Wetering Special Article 26 August 2016 Pages: 323 - 331
2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer Declan WalshMellar DavisAlex Molassiotis Special Article 17 August 2016 Pages: 333 - 340
